GlassScriptPhysician profile
Osama Hallak
NPI 1154852614
$32,719.79
in general payments reported to CMS, 2019-2025
15 companies · $1,061 in 2025
The $1,061 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $221 · 2021: $183 · 2022: $488 · 2023: $170 · 2024: $31K · 2025: $1,061.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $27K · Food and Beverage: $2,704 · Travel and Lodging: $2,319 · Education: $242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $26,563.30 |
| Food and Beverage | $2,703.73 |
| Travel and Lodging | $2,318.85 |
| Education | $242.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $22,658.48 | 2022-2025 | Mitraclip, Perclose Prostyle |
| Medtronic, INC. | $3,721.36 | 2021-2025 | Symplicity G3, Onyx Frontier, Corevalve Evolut R |
| Boston Scientific Corporation | $3,573.58 | 2019-2025 | Watchman Access System, General - Therapies, Synergy |
| Edwards Lifesciences Corporation | $1,344.69 | 2024-2025 | Pascal, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Astrazeneca Pharmaceuticals LP | $300.43 | 2022-2025 | Brilinta, Farxiga |
| Abiomed | $290.29 | 2024-2025 | Impella |
| Chiesi USA, INC. | $145.42 | 2021-2024 | Kengreal |
| Shockwave Medical, INC | $129.11 | 2025 | |
| Penumbra, INC. | $123.55 | 2024 | Indigo System |
| Angiodynamics, INC. | $122.92 | 2024 | Angiovac |
| Polarityte, INC. | $96.93 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $94.33 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $73.09 | 2021-2023 | Lifevest |
| Terumo Medical Corporation | $31.72 | 2025 | Navicross |
| Inari Medical, INC. | $13.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Osama Hallak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.